Cash depletion timeline
Company: Core Scientific
What the later record shows
Outcome not yet confirmed
This was a forecast, not a commitment. The 10-K shows $15.9M of cash and equivalents at December 31, 2022, after the December 21, 2022 Chapter 11 filing. The passages do not settle whether the pre-existing cash was depleted.
“Cash and cash equivalents $ 836,197 $ 50,409 $ 15,884 Restricted cash 783 19,300 36,356”
2025-02-26 · Core Scientific 10-K filed 2025-02-27 View cached copy (2026-08-31)Live source ↗
Checked October 10, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.
The claim, verbatim
Existing cash resources will be depleted by end of 2022 or sooner
Source (primary)
Core Scientific 424B3 filed 2022-10-27 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “The Company anticipates that existing cash resources will be depleted by the end of 2022 or sooner”
How we checked this
Checked on October 11, 2026. The cited source supports every part of this claim.
The October 2022 Form 8-K states that the company anticipates its existing cash resources will be depleted by the end of 2022 or sooner. This is the company's own forward-looking projection, not a report that the cash was actually depleted.
Confirmed in the source:
- As of October 2022, Core Scientific anticipated that its existing cash resources would be depleted by the end of 2022 or sooner
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000119312522270436/d395956d424b3.htm) in full (19,348 characters, retrieved September 13, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific 424B3 filed 2022-10-27
Quote: “The Company anticipates that existing cash resources will be depleted by the end of 2022 or sooner”